Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-20-193772
Filing Date
2020-07-16
Accepted
2020-07-16 09:32:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d96714dsc14d9a.htm SC 14D9/A 19389
2 EX-99.(A)(5)(P) d96714dex99a5p.htm EX-99.(A)(5)(P) 13405
3 GRAPHIC g96714g29y88.jpg GRAPHIC 5466
4 GRAPHIC g96714g99c92.jpg GRAPHIC 5820
  Complete submission text file 0001193125-20-193772.txt   50274
Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Filed by) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address HULSTERWEG 82 PL VENLO P7 5912
Business Address HULSTERWEG 82 PL VENLO P7 5912 31-77-35566-00
QIAGEN N.V. (Subject) CIK: 0001015820 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-54659 | Film No.: 201030868
SIC: 2836 Biological Products, (No Diagnostic Substances)